Earlier this year, three members of Congress introduced what they dubbed the Clean Water for All Life Act. Here’s how this law delivers “clean water for all:” Physicians must examine the bodies of all patients to whom they prescribe abortion medication — that’s in the office, no telemedicine allowed — and hand them a medical waste…
Editors: Holly Fernandez Lynch, Barbara E. Bierer, I. Glenn Cohen, and Suzanne M. RiveracPublisher: MIT PressPublication Date: September 2017 This edited volume stems from a conference in 2015 that brought together leading experts to address key ethical and policy issues raised by genetics and other research involving human biological materials, covering the entire trajectory from specimen source…
Organoids purport to tell us a great deal about the human body. Here are some legal questions to consider as the technology is widely adopted in R&D — and beyond.
In a new paper, Property’s Boundaries, I develop a theory of the boundaries of ownership applicable to bioethics.
Israel’s rich health databases are probably the reason why Pfizer agreed to a deal to expedite deliveries of its vaccine.
By Mason Marks and Tiffany Li An earlier version of this article was published in STAT. The National Institutes of Health wants your DNA, and the DNA of one million other Americans, for an ambitious project called All of Us. Its goal — to “uncover paths toward delivering precision medicine” — is a good one.…
By Nadia N. Sawicki Loyola University Chicago’s nationally acclaimed Beazley Institute for Health Law and Policy is pleased to invite original research submissions for the annual Wiet Life Science Law Scholars Conference to be held on Friday, September 7, 2018. The conference is designed to provide an intellectual venue for life science professors, scholars, and…
Biobanks as Knowledge Institutions “Global Genes –Local Concerns” Seminar with Prof. Michael Madison (University of Pittsburgh, U.S.) Join us at the University of Copenhagen on November 3rd, 2017 to discuss the legal implications of “Biobanks as Knowledge Institutions” with Professor Michael Madison. Abstract The presentation characterizes the material and immaterial attributes of biobanks as knowledge…
By Mary A. Majumder, Christi J. Guerrini, Juli M. Bollinger, Robert Cook-Deegan, and Amy L. McGuire The 21st Century Cures Act was passed with support from both sides of the aisle (imagine that!) and signed into law by then-President Obama late last year. This ambitious legislation drives action in areas as diverse as drug and…
By Alena Buyx, MD PhD Ever wondered what happens to the biological material you leave behind when you check out of the hospital? Nothing much, is the usual answer. However, the little bits of blood, tissue, and urine are potentially valuable for medical research; miniscule amounts of it may already allow sophisticated analyses, including genetic ones.…
